Literature DB >> 23036037

Piperacillin-induced thrombocytopenia reversed by high-flux hemodialysis in an uremic patient.

Shang-Yi Lin1, Jiun-Chi Huang, Mei-Chiou Shen, Shu-Hui Chuang, Mei-Hsuan Lee, Huang-Chi Chen.   

Abstract

Drug-induced thrombocytopenia in an infected patient often is overlooked. We present a 74-year-old uremic female with continuous renal replacement therapy developed severe thrombocytopenia during the treatment course of piperacillin/tazobactam. Platelet counts recovered rapidly after discontinuing piperacillin/tazobactam and receiving high-flux hemodialysis. The George criteria indicates piperacillin/tazobactam as the probable cause of thrombocytopenia in this patient. Immediate withdrawal of the causative drug is important for drug-induced thrombocytopenia. Prompt high-flux hemodialysis may be an adjunctive management for uremic patients.
© 2012 The Authors. Hemodialysis International © 2012 International Society for Hemodialysis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23036037     DOI: 10.1111/j.1542-4758.2012.00745.x

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  2 in total

1.  The potential of antimicrobials to induce thrombocytopenia in critically ill patients: data from a randomized controlled trial.

Authors:  Maria Egede Johansen; Jens-Ulrik Jensen; Morten Heiberg Bestle; Lars Hein; Anne Øberg Lauritsen; Hamid Tousi; Kim Michael Larsen; Jesper Løken; Thomas Mohr; Katrin Thormar; Pär I Johansson; Alessandro Cozzi-Lepri; Jens D Lundgren
Journal:  PLoS One       Date:  2013-11-28       Impact factor: 3.240

2.  Alternative diagnosis to heparin-induced thrombocytopenia in two critically ill patients despite a positive PF4/heparin-antibody test.

Authors:  Gregor Hron; Folke Knutson; Thomas Thiele; Karina Althaus; Christoph Busemann; Sigrun Friesecke; Andreas Greinacher; Norbert Lubenow
Journal:  Ups J Med Sci       Date:  2013-11       Impact factor: 2.384

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.